mRNA



New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

  • The shot, named mFlusiva, is intended for adults age 50 or older
  • Flu vaccines must be updated annually to best match circulating strains of the virus
By AP ·